Chlamydophila Pneumoniae

Chlamydophila pneumoniae is a species of Chlamydophila, an obligate intracellular bacterium that infects humans and is a major cause of pneumonia. It was known as the Taiwan acute respiratory agent (TWAR) from the names of the two original isolates - Taiwan (TW-183) and an acute respiratory isolate designated AR-39. Until recently, it was known as Chlamydia pneumoniae, and that name is used as an alternate in some sources. In some cases, to avoid confusion, both names are given.

C. pneumoniae has a complex life cycle and must infect another cell to reproduce; thus, it is classified as an obligate intracellular pathogen. The full genome sequence for C. pneumoniae was published in 1999. It also infects and causes disease in koalas, emerald tree boas (Corallus caninus), iguanas, chameleons, frogs, and turtles.

The first known case of infection with C. pneumoniae was a case of sinusitis in Taiwan. This atypical bacterium commonly causes pharyngitis, bronchitis and atypical pneumonia, mainly in elderly and debilitated patients, but in healthy adults, also.

Read more about Chlamydophila Pneumoniae:  Life Cycle and Method of Infection, Diseases

Other articles related to "chlamydophila, chlamydophila pneumoniae, pneumoniae":

List Of Sequenced Bacterial Genomes - Chlamydiae/Verrucomicrobia Group
1,044,459 911 Chlamydia trachomatis DUW Chlamydiae 1,042,519 894 Chlamydophila abortus S26-3 Chlamydiae 1,144,377 961 Chlamydophila caviae GPIC Chlamydiae 1,173,390 998 Chlamydophila felis ...
Chlamydophila Pneumoniae - Diseases
... pneumoniae is a common cause of pneumonia around the world it is typically acquired by otherwise healthy people and is a form of community-acquired ... from historically recognized causes, such as Streptococcus pneumoniae, pneumonia caused by C ... pneumoniae is categorized as an "atypical pneumonia" ...
Therapies Under Investigation For Multiple Sclerosis - Other Investigations On Possible Treatments
... Antimicrobial agents against Chlamydophila pneumoniae MS patients are more likely to have detectable levels of Chlamydophila pneumoniae DNA in their cerebrospinal fluid, compared to ... Anecdotal reports of the use of antimicrobial agents against Chlamydophila pneumoniae are favorable, but only one double-blind placebo-controlled trial has been published, in which the ...